Cardiology Online

Home

Welcome

Scientific Committees

Opening Lectures

International Academy of Cardiology Awards

Acknowledgements

Timetable

Participant Letter

Program Topics

Final Scientific Program

Exhibition

General Information

Social Program

List of Exhibitors

Instructions for the Preparation of Posters

Writing Instructions & Sending Your Article(s) to the Proceedings Book

Registration Form

Accommodation

Accommodation Form

Contact Us

 

Sunday,
July 14, 2002
Monday,
July 15, 2002
Tuesday,
July 14, 2002
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions
  Satellite Symposium  
TUESDAY, JULY 16, 2002
8:30 - 13:30   POSTER HALL
 

P301 Poster Session:
NEUROHUMORAL, IMMUNOLOGIC ASPECTS OF HEART FAILURE, NATRIURETIC PEPTIDES

 
Board No.

 

 
1

BRAIN NATRIURETIC PEPTIDE AFTER ACUTE CORONARY SYNDROMES LINKS WITH CARDIAC AND COAGULATION MARKERS
R. Grybauskiene
, J. Cimbolaityte, J. Bluzhas, P. Grybauskas, I. Vaara, R. Tamosiuniene, R. Babarskiene, D. Luksiene, B. Slapikiene, J. Janenaite, Kaunas, Lithuania, Vaxjo, Sweden

 
2

THE PROGNOSTIC VALUE OF CIRCULATING SOLUBLE CELL ADHESION MOLECULES IN PATIENT WITH CHRONIC CONGESTIVE HEART FAILURE
W.-H. Yin, J.-W. Chen, M.S. Young, Taipei, Taiwan, ROC

 
3

EFFECTS OF MOXONIDINE ON HEART RATE VARIABILITY AND ON MYOCARDIAL PERFORMANCE INDEX
I.Moyssakis , N.J. Pantazopoulos, H Mihalopoulou, K. Georgakopoulos, F. Papademetriou, M. Kyriakidis, Athens, Greece

 
 

 

 
 

P302 Poster Session:
INFLAMMATORY MEDIATORS IN HEART FAILURE

 
4

MODULATION OF CRP-MEDIATED INDUCTION OF MCP-1 BY NO-DONATING AND COAGULATION INHIBITING DRUGS
S. Zumhagen, E. Schulze-Bahr, R. Gradaus, P. Loh, B. Brisse, Muenster, Germany

 
5

MAST CELL TRYPTASE IS NOT ELEVATED IN PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
B. Upadhya, J.L. Kontos, F. Ardershipour, J. Pye, W. Boucher, T.C. Theoharides, G.J. Dehmer, E.N. Deliargyris, Winston-Salem, NC, Washinton D.C., Chapel Hill, NC, Tufts University, MA, Texas A & M, TX, USA

 
6

ASSESSMENT OF CARDIAC MYOCYTE INFLAMMATION IN ENDOMYOCAR-DIAL BIOPSIES BY ACTIVATED NF-KB
P. Alter, H. Rupp, B. Maisch, Marburg, Germany

 
 

 

 
 

P303 Poster Session:
HYPERTENSION AND HEART FAILURE

 
7

IS THE SLOWED LEFT VENTRICULAR RELAXATION OR AUGMENTED ATRIAL TRANSPORT FUNCTION THE PRIMARY ABNORMALITY OF FILLING IN MILD HYPERTENSION?
S. Qirko, T. Goda, Tirana, Albania

 
8

DIASTOLIC DYSFUNCTION AND POSSIBILITY OF PHARMACOLOGICAL TREATMENT IN ISOLATED SYSTOLIC HYPERTENSION
S.V. Gurgenyan, S.K. Vatinyan, K.R. Sahakyan, L.B. Edilyan, Yerevan, Armenia

 

TUESDAY, JULY 16, 2002

    POSTER HALL
 

P303 Poster Session:
HYPERTENSION AND HEART FAILURE (cont)

 
Board No.

 

 
9

ECHOCARDIOGRAPHIC EVALUATION OF THE RIGHT VENTRICULAR DIASTOLIC DYSFUNCTION SYSTEMIC HYPERTENSION
S. Qirko, T. Goda, Tirana, Albania

 
10

AGIOTENSINRECEPTOR BLOCKERS AND ACE INHIBITORS IN AFRICAN AMERICAN MEN WITH HYPERTENSION
V. Papademetriou, P. Narayan, P. Kokkinos, Washington DC, USA

 
11

EFFICACY OF CILAZAPRIL IN MILD, MODERATE AND HEAVY ARTERIAL HYPERTENSION
R.M. Zaslavskaya, B.K. Zholdin, I.Z. Talipova, Moscow, Russia, Kazakstan

 
12

THE EFFECT OF DRUG TREATMENT WITH DIET THERAPY ON LEFT VENTRICULAR MASS IN OBESE PATIENTS WITH ESSENTIAL HYPERTENSION
S.K. Vatinyan, S.V. Gurgenyan, K.R. Sahakyan, B.G. Chobanyan, Yerevan, Armenia

 
13

FROM ARTERIAL HYPERTENSION TO INTIMATE INSUFFICIENCYIN PATIENTS WITH POLYCYTHEMIA VERA
G.Gorokhovskaya , E. Peresechensky, A. Martynov, A. Kondrakhin, Moscow, Russia, USA

 
14

METABOLIC EFFECTS OF CILAZAPRIL IN MILD, MODERATE AND HEAVY ARTERIAL HYPERTENSION
R.M. Zaslavskaya, B. Zholdin, I. Talipova, Moscow, Russia, Kazakstan

 
15

NUTRITIONAL STATUS, STRESS, LEVELS OF SERUM LIPIDS AND RED BLOOD CELLS ANTIOXIDANT ENZYMES IN ALGERIAN HYPERTENSIVE PATIENTS TREATED WITH BETA-BLOCKERS
D. Krouf, M. Bouchenak, B. Mohammedi, A. Cherrad, J. Prost, J. Belleville, Oran, Algeria, Dijon, France

 
 

 

 
 

P304 Poster Session:
HEART FAILURE IN WOMEN

 
16

CAN REFERRAL PROBLEMS FOR WOMEN BE CHANGED BY INCREASING CAPACITY?
M. Hochleitner, Tyrol, Austria

 
17

A COMPLETELY REVERSIBLE SEVERE CARDIAC DYSFUNCTION WITH SIGNIFICANT MITRAL INSUFFICIENCY IN HEMOCHROMATOSIS - A CASE REPORT
M.D. Borzanovic, V.M. Stojkovic, B. Borzanovic, A. Vlahovic, D. Kosevic, J.D. Vasiljevic, M. Peric, S. Nastasic, S. Kazic, B. Djukanovic, Belgrade, Yugoslavia

 
 

 

 

TUESDAY, JULY 16, 2002

    POSTER HALL
 

P305 Poster Session:
DILATED CARDIOMYOPATHIES: VARIOUS ETIOLOGIES

 
Board No.

 

 
18

RIGHT VENTRICULAR DIASTOLIC DYSFUNCTION IN SYSTEMIC SCLEROSIS.
THE ASSOCIATION WITH PULMONARY DISEASE

I.Moyssakis , Y. Hallaq, V. Vasiliou, P. Vlahoyannopoulos, N.J. Pantazopoulos, M. Kyriakidis, Athens, Greece

 
19

BECKER MUSCULAR DYSTROPHY PRESENTING WITH DILATED CARDIOMYOPATHY AND COPMPLETE A-V BLOCK IN SIBLINGS
R. Akdemir, C. Uyan, M. Yazici, S. Duran, E. Erbilen, I. Ozer, S. Albayrak, H. Unlu, C. Tataroglu, C. Kirma, Duzce, Istanbul, Turkey

 
20

EVALUATION OF IDIOPATHIC DILATED CARDIOMYOPATHY BY PERCUTANEOUS CARDIOSCOPY
M. Kanai, K. Yoshinaga, T. Sakurai, H. Ohsawa, T. Tomaru, Y. Uchida, Sakura, Chiba, Japan

 
21

THYROTOXICOSIS CAUSING DILATED CARDIOMYOPATHY
N. Shaik, G. DeVaughn, M. Gautam, S. Singh, Darby, PA, USA

 
22

CARDIOMYOPATHY AND MYASTHENIA GRAVIS: CONNECTION OR COINCIDENCE?
M.E. Guglin, J.V. Campellone, K.M. Heintz, Camden, NJ, USA

 
23

CARDIOTROPHIC AND HEPATOTROPIC MIXED INFECTIONS IN DILATED CARDIOMYOPATHY AND VIRAL HEPATITIS
N. Kipshidze, M. Rogava, M. Gudushauri, Tbilisi, Georgia

 
 

 

 
 

P306 Poster Session:
LEFT VENTRICULAR HYPERTROPHY AND HYPERTROPHIC CARDIOMYOPATHY

 
24

ECHOCARDIOGRAPHIC ANALYSIS OF LEFT VENTRICULAR HYPERTROPHY IN CHILDREN AND ADOLESCENTS WITH ESSENTIAL HYPERTENSION
A. Jurko, A. Jurko, Jr., D. Mesko, Z. Farska, A. Sparcova, Martin, Slovakia

 
25

INTERPHASE CARDIOMYOCYTE AGNOR IN MYOCARDIUM FROM PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
A. Gudkova, St.Petersburg, Russia

 
26

INTERPHASE AGNOR OF CARDIOMYOCYTES AND STROMAL CELLS IN PATIENT WITH FAMILIAR OBSTRUCTIVE HYPERTROPHIED CARDIOMYOPATHY
A.Y. Gudkova, E. Semernin, A. Kostareva, K. Korgenevskaya, K. Senchik, S. Lazarev, E. Schlyakhto, St.Petersburg, Russia

 
 

 

 

TUESDAY, JULY 16, 2002

 

 

POSTER HALL
 

P307 Poster Session:
PULMONARY CIRCULATION ASPECTS, PULMONARY
HYPERTENSION

 
Board No.

 

 
27

INCIDENCE OF PULMONARY HYPERTENSION IN SYSTEMIC LUPUS ERYTHEMATOSUS. THE ASSOCIATION WITH ANTIPHOSPHOLIPID ANTIBODIES
I.Moyssakis , N.J. Pantazopoulos, P. Gioldasis, V. Vassiliou, M. Kouli, H. Mihalopoulou, V. Votteas, Athens, Greece

 
28

COR PULMONALE IN THROMBOPHILIC PATIENTS: INDIRECT EVIDENCE FOR IN SITU THROMBOSIS
V. Petrescu, C. Tanaseanu, S. Tanaseanu, I. Racoveanu, V. Bolog, E. Paizis, M. Dorobantu, Bucharest, Romania

 
29

THE PREDICTIVE VALUE OF PULMONARY HYPERTENSION FOR THE COURSE OF POSTINFARCTION PERIOD
R. Komorovsky, Ternopil, Ukraine

 
 

 

 
 

P308 Poster Session:
HEART FAILURE IN INFANCY AND CHILDHOOD

 
30

FAILING FONTAN CIRCULATION SHEEP MODEL AND UTILIZATION OF AXIAL FLOW PUMP - PRELIMINARY EXPERIMENTS
O. Reinhartz, S.R. Reichenbach, A. Ikai, R.K. Riemer, T.R. Karl, San Francisco, CA, Pleasanton, CA, USA

 
31

VARIATION IN SERUM MB ISOENAZYME OF CREATINE KINASE AND CARDIAC TROPONIN I IN CHILDREN WITH VIRAL MYOCARDITIS
J. Xu, L. Liu, J. Li, Y. Ning, Tianjin, China

 
 

 

 
 

P309 Poster Session:
PREVENTIVE ASPECTS OF HEART FAILURE

 
32

PRIMARY PREVENTION IN TURKISH IMMIGRANT WOMEN
M. Hochleitner, Tyrol, Austria

 
 

 

 
 

P310 Poster Session:
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME

 
33

INCREASED LEVELS OF SERUM METALLOPROTEINASES IN PATIENTS WITH CARDIAC CACHEXIA
V. Krokos, N. Prosmiti, S. Xydonas, G. Droungas, D. Balatsouras, D. Evangelou, A. Ambusamala, D. Kardara, G. Filippatos, F. Kardaras, Athens, Greece

 
34

USING TELEMEDICINE TO MANAGE HEART FAILURE PATIENTS
K.H. Lucas, B.R. McKee, H. Baker, D. Rollins, M.B. Schloss, J.G. Rosencrance, Charleston, WV, USA

 

TUESDAY, JULY 16, 2002

 

 

POSTER HALL
 

P310 Poster Session:
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME (cont)

 
Board No.

 

 
35

SERUM PROCOLLAGEN LEVELS IN PATIENTS WITH CARDIAC CACHEXIA
S.Xydonas , N. Prosmiti, V. Krokos, N. Chatzis, A. Ambousamala, D. Manolatos, P. Avgerodimos, D. Kardara, G. Filippatos, F. Kardaras, Athens, Greece

 
36

COLLATERALE VESSELS IN PATIENT WITH ACUTE CORONARY SYNDROMS - PROGNOSTIC FACTOR FOR SEVERITY OF ISCHEMIC HEART DISEASE
M. Dorobantu, R. Niculescu, V. Petrescu, B. Popa, S. Balanescu, D. Constantinescu, M. Marinescu, G. Tatu, M. Guran, P. Capraru, Bucharest, Romania

 
37

THE SIGNIFICANCE OF THE HEART RATE RESPONSE TO STANDING TEST IN DIAGNOSIS OF VAGAL DENERVATION AND CARDIOVASCULAR RISK STRATIFICATION IN PATIENTS WITH DIABETIC CARDIAC AUTONOMIC DYSFUNCTION
B.M. Milovanovic, M. Krotin, L. Vusovic, V. Bisenic, S. Kulezic, N. Hajder, R. Vukovic, J. Ilic, M. Dra

 
38

COMPARATIVE ANALYSIS OF VASCULAR LESION POLYMORPHISMS IN PATIENTS WITH THREE-VESSEL CORONARY DISEASE AND ISCHEMIC CARDIOMYOPATHY
A.M. Arandjelovic, M.M. Asanin, V.P. Stojanov, A.M. Crni, N.D. Kozarevic, Belgrade, Serbia, Yugoslavia

 
 

 

 
 

P311 Poster Session:
MISCELLANEOUS II

 
39

WHAT IS THE PREVALENCE OF OVER-THE-COUNTER MEDICATION USE BY INDIGENT PATIENTS WITH SYSTOLIC HEART FAILURE
L. Arcement, K. Hebert, M. Fleming, P. Glanders, C. Arabie, C. Hebert, G. Bergeron, E. Scott, New Orleans, LA, Houma, LA, USA.

 
40

CAN THE ISCHEMIC REGIONS IN VASOSPASTIC ANGINA PECTORIS BE DETECTED DURING NON-ATTACKING PERIOD?
W. Fujiwara, T. Furuta, S. Kakizawa, O. Inami, T. Kondo, H. Yokoi, Y. Abo, Y. Wtanabe, Nagoya, Japan

 
41

IMBALANCED DIET AND ADVERSE ANTHROPOMETRIC PROFILE IN URBAN ADOLECENTS
R. Sharma, K.K. Talwar, A. Misra, R.M. Pandey, K. Jain, A. Chatterjee, V. Dhingra, N. Khanna, New Delhi, India

 
42

BENEFICIAL EFFECTS OF SELF-MASSAGE OF PROTECTIVE HEART AND ANTIHYPERTENSION ON QUALITY OF LIFE AND PROINFLAMATORY CYTOKINE LEVELS IN CHRONIC HEART FAILURE
X.H. Zeng, Y.H. Zeng, X.J. Zeng, Y. Li, Y.H. Huang, Chengdu, Sichuan, China

 
43

CARDIAC SYMPATHETIC AFFERENT SENSITIVITY IS ENHANCED IN HEART FAILURE
J.J. Zhang, Beijing, China

 
Sunday,
July 14, 2002
Monday,
July 15, 2002
Tuesday,
July 14, 2002
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions
  Satellite Symposium  
 

 

 
 

  Cardiology Online | Home | Welcome | Scientific Committees
Timetable | Program Topics | Final Scientific Program
General Information | Guidelines for Submission of Abstracts | Exhibition
Abstract Form | Registration Form | Accommodation
Accommodation Form | Contact Us